Dual Versus Single Antiplatelet Therapy After TAVR: Let's Not Mix Apples and Oranges

Johny Nicolas; George Dangas

doi:10.1016/j.carrev.2021.11.003

Dual Versus Single Antiplatelet Therapy After TAVR: Let's Not Mix Apples and Oranges

Johny Nicolas
, George Dangas

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	54-55
Number of pages	2
Journal	Cardiovascular Revascularization Medicine
Volume	34
DOIs	https://doi.org/10.1016/j.carrev.2021.11.003
State	Published - Jan 2022

Access to Document

10.1016/j.carrev.2021.11.003

Cite this

@article{2da5112469e149a8897e036bc10db66f,

title = "Dual Versus Single Antiplatelet Therapy After TAVR: Let's Not Mix Apples and Oranges",

author = "Johny Nicolas and George Dangas",

note = "Funding Information: Dr. Nicolas declares that there is no conflict of interest. Dr. Dangas reports institutional research grants from Daiichi-Sankyo, Medtronic, Boston Scientific, and Bayer.",

year = "2022",

month = jan,

doi = "10.1016/j.carrev.2021.11.003",

language = "English",

volume = "34",

pages = "54--55",

journal = "Cardiovascular Revascularization Medicine",

issn = "1553-8389",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Dual Versus Single Antiplatelet Therapy After TAVR

T2 - Let's Not Mix Apples and Oranges

AU - Nicolas, Johny

AU - Dangas, George

N1 - Funding Information: Dr. Nicolas declares that there is no conflict of interest. Dr. Dangas reports institutional research grants from Daiichi-Sankyo, Medtronic, Boston Scientific, and Bayer.

PY - 2022/1

Y1 - 2022/1

UR - https://www.scopus.com/pages/publications/85118978104

U2 - 10.1016/j.carrev.2021.11.003

DO - 10.1016/j.carrev.2021.11.003

M3 - Editorial

C2 - 34774418

AN - SCOPUS:85118978104

SN - 1553-8389

VL - 34

SP - 54

EP - 55

JO - Cardiovascular Revascularization Medicine

JF - Cardiovascular Revascularization Medicine

ER -